How the vaccine developed by Oxford University stacks up against Pfizer and Moderna

AstraZeneca said November 23 that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is easier to distribute than some of its rivals.